New hep C scheme heals pharmacies’ cashflow

It is a good thing that prescription medicines are not considered ordinary items of commerce, because there is no way commercial organisations would accept the funding arrangement faced by community pharmacy in facilitating the supply of hepatitis C treatments.

It is, however, a terrific thing that the availability of several new hepatitis C treatments will ensure we no longer see terrible statistics such as 700 deaths attributable to chronic hepatitis C infection each year, with thousands more suffering a variety of serious liver diseases and conditions